Recent defaults on bonds issued by government-owned Chinese companies raise doubts about credit assessment and the notion that state ownership provides a level of security.
Category: Asset Class in Focus
Can pharma and biotech ease pain in a financial crisis?
Ten years after the global financial crisis of 2008, FSA notes that pharmaceutical, healthcare and biotech stocks weathered that year better than other sectors.
Are listed family businesses the safer bet?
Concerns about family-owned companies tend to be distorted and data shows they outperform their non-family counterparts, according to Jean Keller, CEO of Quaero Capital.
The promise of absolute return strategies
Absolute return fixed income strategies are meant to be a component of a portfolio that reduces overall risk, according to Alex Johnson, BNP Paribas Asset Management’s New York-based head of multi-strategy for absolute return fixed income.
Invesco Great Wall tops best China fund ideas
Morningstar’s semi-annual report on China’s best mutual fund ideas chose 16 onshore funds based on fund manager experience, consistency in investment process and performance in several market cycles.
Multi-asset: A question of balance
FSA takes a look at top-performing multi-asset funds to see how “balanced” they are. The results might surprise.
ASI moves into China’s onshore bond market
Aberdeen Standard Investments’ launch of a China bond fund in Europe signals a pick up in global manager interest in China’s $9trn onshore bond market.
Are policy funds staying true-to-label?
Riding China’s policy bus is not as easy as it sounds, as the poor performance of China policy-driven funds shows.
UBS Wealth in big hedge fund push
UBS Wealth Management is recommending clients allocate up to 20% of their assets to hedge funds as a diversifier, especially in an environment where interest rates and volatility are increasing, according to the firm’s executives.
How to weather sector rotation
Managing sector rotation is the most challenging aspect of equity investing, and the best solution is to wait it out, argues Michael Buhl-Nielsen, fund management director at Jupiter Asset Management.
